PCI Launches Innovative Product Line: Phosphonic Acids, Used in a Wide Variety of Commercial Applications
05. Dezember 2013 09:46 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Dec 5, 2013) - PCI (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufacturers new chemical entities (NCEs), generic active...
MassBio's First CRO/CMO Symposium on "Accelerating Drug Development" Met With Huge Success
14. März 2012 11:28 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Mar 14, 2012) - The inaugural Massachusetts Biotechnology Council (MassBio) CRM/CMO Symposium was a resounding success, according to Ed Price, President of PCI...
PCI Sponsors MassBio's Massachusetts CRO/CMO Symposium
15. Februar 2012 14:16 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Feb 15, 2012) - PCI (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients...
PCI Synthesis Adds Manufacturing, QC, Business, and R&D Expertise
31. Januar 2012 10:17 ET
|
PCI Synthesis
NEWBURYPORT, MA and NEW ORLEANS, LA--(Marketwire - Jan 31, 2012) - Informex, Booth 425 -- PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical...
PCI Synthesis Completes R&D Expansion
13. Dezember 2011 12:44 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Dec 13, 2011) - PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis Announces 8th Successful FDA Inspection
15. November 2011 10:33 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Nov 15, 2011) - PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...